Statement of Changes in Beneficial Ownership (4)
07 January 2022 - 8:03AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Robbins Jim B |
2. Issuer Name and Ticker or Trading Symbol
VIVEVE MEDICAL, INC.
[
VIVE
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) SVP, Finance & Administration |
(Last)
(First)
(Middle)
C/O VIVEVE MEDICAL, INC., 345 INVERNESS DRIVE S., BLDG B, STE 250 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
1/4/2022 |
(Street)
ENGLEWOOD, CO 80112
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Incentive Stock Option (Right to Purchase) | $1.26 | 1/4/2022 | | A | | 42000 | | (1) | 1/3/2032 | Common Stock | 42000 | $0 | 42000 | D | |
Explanation of Responses: |
(1) | The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan, as amended (the "2013 Plan") and received 42,000 incentive stock options on January 4, 2022 (the "Grant Date"). The incentive stock options shall vest and become exercisable in 48 equal monthly installments from the Grant Date. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Robbins Jim B C/O VIVEVE MEDICAL, INC. 345 INVERNESS DRIVE S., BLDG B, STE 250 ENGLEWOOD, CO 80112 |
|
| SVP, Finance & Administration |
|
Signatures
|
/s/ Jim Robbins | | 1/6/2022 |
**Signature of Reporting Person | Date |
Viveve Medical (NASDAQ:VIVE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Viveve Medical (NASDAQ:VIVE)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Viveve Medical Inc (NASDAQ): 0 recent articles
More Viveve Medical, Inc. News Articles